We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Secure Cloud-Connected qPCR System Enables Remote Infectious Disease Surveillance

By LabMedica International staff writers
Posted on 10 Sep 2026

Rapid infectious disease detection and monitoring require secure, timely access to molecular test data across distributed sites. More...

As point-of-care quantitative PCR (qPCR) expands, remote control, biosurveillance integration, and data protection remain challenges. To meet these needs, a new system adds secure cloud connectivity and hardware-level security to portable qPCR instruments, supporting remote operation, real-time aggregation, and integration with analytics and artificial intelligence.

Anitoa Systems (Sunnyvale, CA, USA) has added comprehensive cloud connectivity and enterprise-grade security to its portable qPCR instruments. The update is designed to bring cloud capabilities to the edge of diagnostic testing, improving flexibility and data access for researchers, clinicians, and public health teams. The company positions the enhancement as a step toward more connected decentralized molecular workflows and better coordination across testing sites.

The cloud-enabled architecture allows users to remotely access instruments for data collection, experiment setup, and real-time monitoring. Devices are controlled through a secure Hypertext Transfer Protocol Secure (HTTPS) interface using a customizable, cross-platform web application. This configuration enables operators to manage diagnostic workflows from virtually any device without being tied to the instrument’s physical location.

Centralized cloud-based data storage also enables direct feeds into large-scale analytics platforms and supports artificial intelligence integration. The capability is described as particularly important for continuous biosurveillance, allowing health organizations to aggregate diagnostic data in real time across multiple locations. This could help identify emerging pathogen trends and support rapid, data-driven outbreak responses on a global scale.

Security features are embedded at the hardware level to protect sensitive diagnostic information. Each device includes a dedicated hardware security root-of-trust module within the electronics subsystem to enable hardware-level encryption. The approach is intended to make instruments tamper-resistant and physically unclonable, securing data from the point of collection through cloud transmission while protecting user information and patient privacy.

The instruments retain a portable, calibration-free design with low power consumption, enabled by Anitoa’s proprietary ultra-low-light complementary metal-oxide semiconductor (CMOS) bioimaging sensor. By pairing this optical technology with secure cloud connectivity, the system is intended to expand access to molecular testing, including in remote settings.

Related Links
Anitoa Systems


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study design and workflow (Parankusham H, Vanderlip C, Birkenbihl C, et al. A two-stage plasma biomarker algorithm reduces amyloid PET use and the p-Tau217 gray zone. Annals of Clinical and Translational Neurology. Published online October 19, 2026. doi:10.1002/acn3.70560)

Two-Step Blood Testing Approach Reduces Uncertainty in Amyloid Assessment

Blood-based biomarkers offer a more accessible, less expensive way to detect Alzheimer’s-related brain changes than traditional methods such as amyloid-beta positron emission tomography (Aβ-PET).... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: HETA Quality Control identifies slide quality issues before analysis, while HETA Tumor Detect annotates tumor regions and flags slides likely to contain tumor during scanning. (Photo courtesy of Aignostics)

AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

Pathology laboratories often rely on visual review of tissue slides to assess quality, identify tumors, count mitoses, and estimate tumor content. These tasks can be time-consuming and vary between readers,... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.